跳至主要内容
临床试验/TCTR20210221001
TCTR20210221001已完成不适用

Severity of ototoxicity and long-term hearing outcome in pediatric oncology patients receiving cisplatin in a university hospital

none0 个研究点目标入组 47 人开始时间: 2021年2月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
47

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
1 Years 至 15 Years(—)
性别
All

入选标准

  • 1.pediatric solid tumor patients including neuroblastoma, hepatoblastoma, osteosarcoma, and germ cell tumor who were younger than 15 years old and received cisplatin-based chemotherapy at the Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand from January, 2007 to December, 2019, 2.Patients were evaluated baseline hearing with audiogram and/or auditory steady-state response (ASSR) pre- or within 1 month of initiation of cisplatin and were followed up the hearing test at least 2 sequential times.

排除标准

  • Patients who had anatomical defect of ear and renal dysfunction before treatment.

研究者

发起方
none

相似试验